1. Home
  2. TLX vs DRH Comparison

TLX vs DRH Comparison

Compare TLX & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$9.15

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

HOLD

Current Price

$9.29

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLX
DRH
Founded
2015
2004
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TLX
DRH
Price
$9.15
$9.29
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$21.13
$10.08
AVG Volume (30 Days)
275.4K
1.8M
Earning Date
04-17-2026
04-30-2026
Dividend Yield
N/A
3.75%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2.99
Revenue Next Year
N/A
$2.08
P/E Ratio
$150.33
$38.41
Revenue Growth
N/A
N/A
52 Week Low
$6.28
$6.19
52 Week High
$19.93
$10.67

Technical Indicators

Market Signals
Indicator
TLX
DRH
Relative Strength Index (RSI) 68.42 42.91
Support Level $8.85 $9.07
Resistance Level $9.92 $9.37
Average True Range (ATR) 0.25 0.23
MACD 0.11 -0.01
Stochastic Oscillator 91.46 20.34

Price Performance

Historical Comparison
TLX
DRH

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: